Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Identifying where to find free finance classes can open doors to valuable learning. Discover resources that can help you improve your financial skills.
17,032 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...
A little-known aerospace stock has delivered a blistering 470% gain over five years and recently reached a fresh all-...
Investors have long looked to deals to jumpstart Netflix's growth. Five paraphrased lines from Netflix's co-CEO revea...
CECO (CECO) 2025 earnings will hinge on project backlogs, margins, and demand for air quality and energy solutions. T...
Oil edges toward a $100 threshold as geopolitical tensions intensify. Four key energy names—Exxon, Chevron, ConocoPhi...
Meta is plowing ahead with AI investments. This article explains why the reason meta's spending spree could stay on t...
AMD posts a sharp rise in free cash flow as data center demand surges, while Intel bankrolls a costly foundry rebuild...
When the chips slide, investors hunt for the best pick. This guide weighs Marvell and Broadcom as the market cools, o...
Investors pushed Microsoft higher as AI software leadership and new deals fueled optimism. This deep dive explains th...
As Netflix stumbles, investors wonder if Disney down 2026 offers a rare contrarian opportunity. This article digs int...